Shandong Provincial Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 2022-03-18
- Employees
- -
- Market Cap
- -
- Website
- http://www.sph.com.cn
The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study
Active, not recruiting
- Conditions
- Early Hepatocellular Carcinoma
- Interventions
- Procedure: MWA
- First Posted Date
- 2023-10-24
- Last Posted Date
- 2023-10-24
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 334
- Registration Number
- NCT06096896
- Locations
- 🇨🇳
Shandong PH, Jinan, China
Endocrine Glucose & Lipids Metabolism and Brain Aging: a Longitudinal Study
Recruiting
- Conditions
- Brain Aging Related Conditions
- First Posted Date
- 2023-10-04
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT06066775
- Locations
- 🇨🇳
Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis
Not Applicable
Active, not recruiting
- Conditions
- Chronic Atrophic Gastritis
- Interventions
- Biological: Mononuclear cellsDrug: Weifuchun+Hydrotalcite/L-Glutamine and Sodium Gualenate Granules
- First Posted Date
- 2023-04-11
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05808010
- Locations
- 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China
A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection
- First Posted Date
- 2023-01-25
- Last Posted Date
- 2023-02-27
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 410
- Registration Number
- NCT05697055
- Locations
- 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China
Association Between Multiple Coagulation-related Factors and Lymph Node Metastasis in Patients With Gastric Cancer: A Retrospective Cohort Study
Recruiting
- Conditions
- Lymph Node MetastasisGastric Cancer Stage
- Interventions
- Diagnostic Test: coagulation-related factors
- First Posted Date
- 2022-10-25
- Last Posted Date
- 2022-10-25
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 516
- Registration Number
- NCT05592925
- Locations
- 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China
High-power Green-light Laser Endoscopic Submucosal Dissection for Non-muscle-invasive Bladder Cancer
Completed
- Conditions
- Bladder Cancer
- First Posted Date
- 2022-03-22
- Last Posted Date
- 2022-03-22
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 45
- Registration Number
- NCT05290623
- Locations
- 🇨🇳
Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma
Phase 3
Recruiting
- Conditions
- Mantle Cell LymphomaHigh Grade B-Cell Lymphoma, Not Otherwise SpecifiedHigh Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsDiffuse Large B Cell LymphomaB-cell Non Hodgkin Lymphoma
- Interventions
- Drug: Zanubrutinib+R-CHOP; Zanubrutinib+R-DA-EPOCH; Zanubrutinib+R-HD MTXDrug: R-CHOP; R-DA-EPOCH; R-HD MTX
- First Posted Date
- 2021-12-21
- Last Posted Date
- 2021-12-21
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 160
- Registration Number
- NCT05164770
- Locations
- 🇨🇳
Department of Hematology, Shandong Provincial Hospital, Jinan, Shandong, China
Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma
Phase 3
Recruiting
- Conditions
- High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsMantle Cell LymphomaB-cell NonHodgkin LymphomaHigh Grade B-Cell Lymphoma, Not Otherwise SpecifiedDiffuse Large B-cell Lymphoma
- Interventions
- Drug: Orelabrutinib+R-CHOP; Orelabrutinib+R-DA-EPOCH; Orelabrutinib+R-HD MTX;Orelabrutinib+R+other chemotherapies
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2021-11-19
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 130
- Registration Number
- NCT05097443
- Locations
- 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China
HBOT in the Treatment and Prevention of aGVHD
Not Applicable
Recruiting
- Conditions
- Acute-graft-versus-host DiseaseHyperbaric Oxygen Therapy
- Interventions
- Device: Hyperbaric oxygen therapy
- First Posted Date
- 2021-10-14
- Last Posted Date
- 2021-10-14
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05078073
- Locations
- 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China
Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors
Phase 4
- Conditions
- Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease
- Interventions
- First Posted Date
- 2021-02-04
- Last Posted Date
- 2021-02-04
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 230
- Registration Number
- NCT04738955
- Locations
- 🇨🇳
Department of Hematology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China
© Copyright 2025. All Rights Reserved by MedPath